Home
MyCare - Patients: View your medical records securely online here.
Log in Learn More

WARCEF - Warfarn vs. Aspirin in Reduced Cardiac Ejection Fraction

Description: WARCEF - Warfarn vs. Aspirin in Reduced Cardiac Ejection Fraction. Includes Change in Eligibility Criteria (Eligibility Ejection Fraction Has Been Increased From less than 30 to less than 35%) To compare the efficacy and safety of Warfarin (INR 2.0-3.0) with aspirin (325 mg per day) for preventing all-cause mortality and disability in patients with cardiac EF less than 35%.
IRB Number: NIH 683
Notes: NIH
Status: Enrollment Complete; Intervention Continues
Start Date: January 01, 2002
Principal Name: W. Scott Burgin, MD
Contact Name: Cheryl Weber, RN, MS, CCRC
Phone: 585-922-4111
Alternative Phone: 585-922-4371